Dracen Pharmaceuticals' Unattributed VC Round

Dracen Pharmaceuticals raised a round of funding on January 24, 2018. Investors include Deerfield Management.

Dracen Pharmaceuticals is a biotech company focused on developing cancer metabolism/immuno-oncology small molecule therapeutics.…

Articles about Dracen Pharmaceuticals' Unattributed VC Round: